Dr. Lisa M. Nijm, MD, JD, is an internationally acclaimed corneal, cataract, and refractive surgeon, licensed attorney, and trailblazer in healthcare innovation. As founder and CEO of Warrenville EyeCare & LASIK, she brings a rare combination of surgical precision, legal acumen, and strategic foresight that has positioned her as a trusted leader and advisor across the pharmaceutical and medical device industries.

Her cross-disciplinary leadership has led to measurable industry impact. As Chief Medical Advisor, she was instrumental in guiding TruKera Medical through its acquisition by Bausch + Lomb. She continues to shape strategic direction as a Medical Advisory Board member for Azura Pharmaceuticals and Nordic Pharma. Dr. Nijm serves as an Assistant Clinical Professor of Ophthalmology at the University of Illinois Eye and Ear Infirmary and sits on the Board of Directors of the Cornea Society. She also recently completed her term with the American Academy of Ophthalmology Executives (AAOE). As CEO of Women in Ophthalmology (WIO), Dr. Nijm has driven transformative growth—elevating the organization into one of the top three largest ophthalmology meetings in the U.S.

A dynamic educator and thought leader, Dr. Nijm is also a highly sought-after speaker and peer-reviewed author. As Course Director for the Osler National Board Review Course, she has played a central role in preparing more than 2,500 ophthalmologists for board certification—shaping the next generation of leaders. Consistently ranked among the most influential ophthalmologists worldwide, Dr. Nijm's impact resonates with multiple appearances on The Ophthalmologist’s Power List, Newsweek’s America’s Best Ophthalmologists, and Castle Connolly’s Top Doctors.

Beyond her clinical and academic roles, Dr. Nijm has developed two respected resources: MDNegotiation.com and RealWorldOphthalmology.com (RWO). Drawing on her MD/JD background, she created MD Negotiation, a specialized curriculum that has empowered over 1,300 physicians and 40 residency programs with essential negotiation skills.

Further, RWO, a free educational platform, has gained global recognition and become a cornerstone of education for early-career surgeons. Through engaging virtual meetings, robust networking events, insightful podcasts, timely board reviews, and ongoing social media education, RWO attracted more than 5,000 young ophthalmologists from 115 countries in three years.

Dr. Nijm’s unique multidisciplinary expertise, innovative contributions, and visionary leadership have made her a prominent figure in ophthalmology—recognized for bridging clinical excellence with transformative leadership and industry-shaping strategy.